AMA Will Help you Choose and Learn About E-Prescribing

Well if you have not located enough information yet, the AMA has a web based tool for you to compare systems and prices.  I didn’t see any mention of the free NEPSI system though, but perhaps they were only comparing the full featured systems. You can use the link on this site to look at NEPSI if you like as it uses the Allscripts program and gets the job done, but the one you pay for has some additional whistles and bells.

It would be nice to have some testimonials from physician members reaping some benefits, that always helps and it looks more like a “do as we do” initiative instead of a “do as I say” presentation and if any are utilizing any features that will drop the information into a PHR.    I tried the locator myself and didn’t see an option for one that can send the information to a PHR, like the HealthVault project that was announced a couple weeks ago.  At any rate, here’s the site for additional information.  BD 

American Medical Association and HealthVault to Provide Physician’s Portal – Physicians Will be able to access “Patient Shared” Information

image

A recent survey found about 30 percent of physician participants use an ePrescribing system in their practice. This is a sizable increase from the 13 percent who said the same at the end of last year," said AMA Board Member Joseph M. Heyman, MD. "With the current Medicare ePrescribing incentive and the promise of increased patient safety and practice efficiency, physician interest in adopting new technologies is increasing. We are glad to be able to offer physicians guidance on ePrescribing."

AMA - AMA Unveils Enhanced ePrescribing Learning Center

One Woman’s Battle with Ingenix Who Has Cancer

The Ingenix data base story has now graduated up to ABC News.  They also provide other services to insurers and provide your prescription data along with another company.  You can read more here.

Health Insurance Underwriting Practices With Prescription Data – How Does This Work

Recently an insurance executive also testified in front of the Senate on some of the practices from his inside view for years, good reading nice to be informed.  Health Insurance is almost like Forest Gump stated, “its like a box of chocolates, you just don’t know what you are going to get”.  BD

Senate Testimony – Insurers Confuse Consumers and Dump Those Who are Sick, a Wall Street Run System

After being diagnosed with ovarian cancer in 2006, surgery and chemotherapy helped the Yonkers, N.Y., woman enter remission for more imagethan a year. But the cancer recurred last October and Jerome is fighting for her life once more.

No matter how this new battle ends, Jerome said she's grateful for at least one victory: her struggles with her health insurance company will help bring about the demise of a database that critics say allowed insurers to routinely rip off patients who sought "out-of-network" care -- medical care outside of a patient's insurance company network. 

While insurance companies have defended the database containing market rates for hospital procedures -- run by a company known as Ingenix -- they nonetheless have agreed to provide millions of dollars to discontinue the database and create a new, independent one in its place. Government officials told ABCNews.com that they are optimistic that the new database will be in operation by early next year.

These days, Jerome said, her health insurance company -- she now gets her coverage directly from UnitedHealth -- treats her very well.

"They know who I am now," she said with a chuckle. "I'm infamous in their eyes."

Health Insurance Charges - ABC News

Sensei® Robotic Catheter System Does Heart Surgery at Scripps in San Diego

This is a case where you may want your interventional radiologist and/or cardiologist close at hand, literally.  This robot from Hansen is a bit different than the DaVinci imagethat we are probably all familiar with at this point.  This one is specifically made for catheter surgeries.    The robot at Scripps performed along with the surgeon of course it’s first heart surgery. 

The robotic process can help with some of the plotting of the path to follow, which is now done with various types of images, even x-rays before the surgery takes place. 

  image

Recently I have a couple interviews on the site here that describe a bit more about interventional procedures.  I spoke at length with Dr. Bart Muhs Assistant Professor of Vascular Surgery and Radiology Co–Director of Endovascular Surgery at Yale University about the surgical processes and he took quite a bit of time to explain.

Interview with Bart E. Muhs, M.D., Yale School of Medicine – Aneurysm Repair Surgery

image

The robot I’m almost positive will be expanded into other areas as well, you can read more about what is being done with catheters with Leg therapies below.  BD 

Cook Medical Interview Discussing PAD Leg Therapies– Rob Lyles, VP Peripheral Intervention Division

A new robotic heart catheter system offers new hope for the more than 2.2 million Americans who suffer from atrial fibrillation. The procedure, called a catheter ablation for supraventricular tachycardia, is a common arrhythmia that typically occurs in healthy people and is characterized by palpitations or a racing pulse. Driven by a joystick from a control station next to the patient, physicians at Scripps Memorial Hospital La Jolla are now able to maneuver the robotic catheter with pinpoint precision, much like a video game.

Robot Perfoms Delicate Heart Surgery: CBS Channel 8 - Scripps Health - San Diego

President Obama Gets Interrupted by a Duck – Cell Phone That Is

Well obviously I don’t have the market cornered on this one, but yes I do have a cell phone that quacks, but being my last name is “Duck”, I think I am well entitled to have my phone quack!

It is funny though and always raises a smile and a laugh.  One of the questions that arises is “how did you make your phone quack?” In selecting a duck tone for my phone, I really did have to be selective, as you can hear in the video, it is a quiet tone, not one that quacks continuously, not one that is mad, and for sure not a cackling duck and for goodness sakes not one laying an egg.  

My duck has 3 very brief quacks, somewhat quiet but enough to get one’s attention and doesn’t carry on for more than a second, so I have to say just like the tone in the video, I have a polite “duck phone”, but one think that I do like is the fact that nobody else is confusing the tone thinking it might be their phone!  

As you can see in the video, any time a duck quacks “people listen” (grin).  There used to be a commercial for E. F. Hutton, saying the same thing that when…….talks, people listen. 

By today’s standards that is outdated and now we are left with the “call of wild” and sometimes some of the calls I receive resemble that comment.  Nobody listens to E.F. Hutton anymore, the “Ducks” have it!!  BD 

Johnson and Johnson and Abbott Labs – Battle for Intellectual Property Solved – Expensive for Abbott

Legal suits are still ramped with drug companies in the court rooms, this one has to be one of the largest settlements I am aware of, over a billion dollar infringement over the patent, or aka Intellectual Property as sometimes referred to today.  The two drugs in question were Humira from Abbott and Remicade from Johnson and Johnson.  image Here’s a related link with a little history on the case.

Lately there have been other similar battles in court, such as generic company Teva questioning the patent from Merck with Singulair.  As the push for generics rises, we may see more of these, thus the patent lifetimes may tend to shrink, as the money for such purchases are getting slim.

Merck and Teva Go to Court over Singulair Going Generic
What’s in a Drug Patent for Pfizer – There are several Court Cases are Challenging Others Too

Humira had over 4 billion in sales last year, and had actually started R and D 2 years before J and J began with Remicade.  Both drugs fall into the human antibody category, thus share some similar properties and are prescribed for the same illnesses.   As cheaper drugs emerge the battle is on for the big name cash cows for big pharma.  BD 

LOS ANGELES — A unit of Johnson & Johnson said Monday that a federal jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over the companies' rheumatoid arthritis drugs.

Abbott's best-selling drug, Humira, competes with the drug Remicade, an anti-TNF class of arthritis treatments made by J&J's Centocor. That company and New York University filed a patent infringement suit against North Chicago, Ill.-based Abbott in April 2007 in the Eastern District of Texas.

Anti-TNF refers to drugs which block tumor necrosis factor proteins in the blood. When present in excessive amounts, TNF can cause inflammation, which leads to many of the symptoms suffered by those with autoimmune disorders like RA.

J&J unit wins $1.67 billion verdict vs Abbott Labs

Courts Charge Mother With Neglect – Failing to Control Son’s Weight of 555 Pounds

5 to 10 years for obesity or child neglect is the potential sentence if convicted for the mother.  She was instructed to bring her son in for medical imagetreatment and didn’t show.  There are a lot of unanswered questions here too, could she afford the treatment or was the tab being picked up.  That is the first thing that comes to mind for me.  He’s in protective custody now so someone will be watching what he eats.  BD 

Authorities are searching for his mother Jerri Gray who failed to make a scheduled court appearance on May 19, 2009. The judge has ordered the 555 pound teen be taken into protective custody because of medical neglect and Gray's failure to appear in court.

Before fleeing town with her son, Jerri Gray had been contacted by the local Department of Social Services previous times about her son's weight and was even issued a treatment plan to turn around Alexander Draper's morbid obesity, Gray's attorney Grant Varner told ABCnews.com.

But when Gray failed to bring Alexander in for some of his medical treatment appointments recommended by the department and he continued to gain weight, the state sent notice that Gray would lose custody of her only child.

Courts Charge Mother of 555-Pound Boy - ABC News

California Insurance Commissioner Want to Know How Much Money Insurers have invested in Iran

This could be interesting to see what comes to table from the inquisition as such are considered illegal, and then again what if none are reported and nobody comes to the table?  If something is found this could be a new move for transparency it seems.  BD 

Reporting from Sacramento -- State Insurance Commissioner Steve Poizner thrust California further into foreign policy areas usually left to Washington by ordering insurance companies to tell him whether they've invested money in Iran, a nation identified by the U.S. government as a sponsor of state terrorism.
Poizner, a Republican seeking his party's nomination for governor next year, said Monday that he had issued a "data call" to 250 insurers headquartered in the state and 1,500 others that are licensed to sell policies in California.

At a Los Angeles news conference, Poizner said he had authority under a state law that took effect Jan. 1 to require California-based insurers to report any investment they have in the government of Iran or in the defense, nuclear, petroleum, natural gas or banking areas of Iran's economy. Such investments are illegal under state and federal statutes, he said.

California Insurance Commissioner Steve Poizner orders insurers to reveal Iran investments - Los Angeles Times

Support for PHRs gaining ground in the UK – Cost, Privacy and Ownership Leading Factors

The government in the UK is looking at cost as well and the anticipated cost of expanding the data facilities of the NHS.  This report states they imageshould scrap it, but I don’t think that would be the entire answer either, but adding the ability to have their own PHR would certainly help.  The NHS has done a lot of things right but has been plagued with data breaches, not break ins, but rather hardware issues with people taking information off the network and losing it, which really is not a good idea anywhere and it happens here too.  Support for PHRs is a growing issue as we all would like to see and have some control over our medical records.  BD 

The government should scrap its £16.5 billion annual expenditure on centralized databases. 

These systems often do not work properly and also have serious privacy implications, according to a high level report, according to a new paper from the right-of-centre Centre for Policy Studies.

The report's publication, days after Conservative leader David Cameron launched a scathing attack on the Labour government's databases, is another sign that multi-billion pound IT projects, are likely to become an election battleground.

The new report, It's Ours: Why we, not government, must own our data, argues the government does not understand IT or how to manage IT projects, with 70 percent failing.

"The alternative is to use services such as HealthVault or Google Health to encourage and enable the individual citizen to use to store and analyze their own health records," the report stated.

"This alternative would eliminate the need for the NHS database, and be practically cost-free." It required service oriented architecture and cloud computing environments, the report stated. Such an approach could depend on open data standards, it suggested.

Government IT to be key election battlegound - Network World

Teva, Antares get FDA Approval for Growth Hormone Needle Free Device

This has been a pain for kids with injections, so it looks like soon kids will have a choice.  Antares has several devices on the site, one pictured imagebelow, which may or may not be the specific one used. 

Recently a study with inhaled growth hormones was conducted as well. This is reported to be the first of five products to be released from the partnership with Antares and Teva.  BD 

Inhaled growth hormone safe for children - Study

 Teva has been one busy company of late if not in the R and D area, plenty of legal challenged with Merck and Amgen with intellectual property challenges.  BD 

Teva, the world's largest generic drug maker, and Antares filed a supplemental new drug application last year to use the needle-free device to administer Tev-Tropin, a human growth hormone.

Human growth hormone is a protein, given by injection, that is commonly used to treat children with growth hormone deficiency.

UPDATE 2-Teva, Antares get FDA nod for needle-free device | Markets | Markets News | Reuters

Heart Stem Cell Trial at Cedars Sinai – Patient’s Own Cells Injected to Reverse Heart Attack Damage

Finally the work and benefits of stem cells are beginning to evolve around us.  The patient had a heart attack, had permanent damage and by injecting his own stem cells the efforts of this procedure will hopefully reverse the damage and scarring done by the attack.  The program is under trial at Cedars Sinai in Los Angeles.  "Cardio-spheres" are created and can even start beating in the dish.  (video below).  This was a big decision and we certainly hope it works for him.  BD 

The Heart Can Repair Itself – Stem Cells Help Speed up the Healing

Also, from earlier this year at the TED conference in Long Beach, there was an excellent presentation on regenerative medicine and in part of the 20 minute video you can see stem cells actually being injected into a beating heart.  BD 

Regenerative Medicine, Robots, Stem Cells and Body Tissues and the Financial Crisis

(CBS) In a heart attack, the blood supply to part of the heart is shut off by a clot in a clogged artery - causing scarring of the heart muscle, which reduces the ability of the heart to pump.
The best that doctors have been able to do is to promptly open up the clogged artery and limit the damage with drugs.
But one day, there may be a way to get that damaged heart to grow its own brand-new muscle tissue. How? By using the patient's own cardiac stem cells.
This week doctors in Los Angeles have given a heart attack patient an infusion of stem cells grown from his own heart muscle.

So he volunteered be one of 24 recent heart attack patients in a cutting-edge clinical trial at the Cedars-Sinai Heart Institute - becoming the first person ever to get an infusion of his own heart stem cells.
"We seek to actually reverse the injury that has been caused by the heart attack, by re-growing new heart muscle to at least partially replace the scar that's formed," says Dr. Eduardo Marban of Cedars-Sinai Heart Institute.  In a trailblazing procedure new cells grow spontaneously from the specimens eventually forming into clusters called "cardio-spheres" that can even start beating in the dish. In 4 to 6 weeks, there are millions of stem cells.

Fixing The Heart With Stem Cells - CBS Evening News - CBS News

Medtronic Pacemaker that can allow an MRI Procedure approved in Europe

Finally, but not here in the US yet, a pacemaker that will allow a patient to have an MRI.  No word on how long before we may see FDA approval here in the US.  (picture at the right does not necessarily represent the device approved)  BD 

MINNEAPOLIS -- Medical-device maker Medtronic Inc. said Friday it received European Union marketing approval for a new version of a imagepacemaker that can be used in an MRI machine.

Medtronic ( MDT - news - people ) said the Advisa DR MRI SureScan pacing system has been approved. The company said patients with pacemaker implants are discouraged from having MRI scans because the machinery could interfere with the functioning of the pacemaker. The Minneapolis company estimated that between 50 and 75 percent of pacemaker patients worldwide need an MRI scan at some point, and that about 2 million Europeans have pacemakers.

Medtronic says EU approves new MRI-safe pacemaker - Forbes.com

Bioidentical Hormone Replacement Therapy– Interview with Dr. Erika Schwartz

image

I had the opportunity to chat with Dr. Erika Schwartz recently about Bio Identical Hormone Therapy, one of the foremost experts in the United States on the subject. She has written 4 best selling books and is also seen on Extra Lifechanger. Dr. Erika trained at Kings County Hospital Center in Brooklyn, NY in Internal Medicine and Critical Care on the front lines and became the Director of Emergency Medicine at Westchester County Medical Center. She also lectured on the topic of bioidentical hormones at Harvard University/Massachusetts General Hospital.

imageShe is also the founder of America’s first physician-led, fully-accredited CME institute dedicated to training physicians in the clinical use of bioidentical hormones for aging, prevention, and wellness, the Bioidentical Hormone Initiative.

The conversation was very enlightening and even motivated me to do some additional research on my own. This subject has been so long misunderstood, and me included with limited knowledge. After our discussion I have a much better idea about not only what the products and treatment processes are, but also read up about the history on how hormone therapy came into existence.

We started out talking about Premarin and all the controversy around the drug over the years with cancer. First off all she explained to me exactly what Premarin is in detail. I knew it was a hormone pill, but other than that I didn’t have much knowledge to speak of.

Premarin she said has been the leading estrogen product for years, and is made from the urine of pregnant mares which is bio-identical if you happen to be a horse. Horse estrogen is foreign to our bodies, where as a molecular derivative created that is like what is naturally found in our bodies would have a better outcome. Our body has to figure out what to do with Premarin and how to metabolize the estrogen from horse since we are human. (Note: Due to some lagging sales, Wyeth has also recently increased the price of Premarin.)

Bio-identical hormones to many, and self included here are a confusing issue as there are both the drugs which are standardized dosages and approved by the FDA, and those that are personally compounded at pharmacies, which means is a custom mix and not out of the box or bottle. When many today seem to think of bio-identical hormones, we automatically believe that they are only drugs compounded by the pharmacy, and that is simply not true. Bioidenticals are synthesized hormones that mimic those produced in women's ovaries, more natural than those produced from

horses. You can read more about Estradiol and Levonorgestrel here.

Dr. Schwartz named several FDA-approved drugs that are bio identical to include Estrace, Evamist, Vagifem, Estraderm, and Climara for estrogen and Prochieve, Prometrium, and Crinone for progesterone. Well guess what, I had been using an FDA bio identical drug and didn’t even know it, so there again is where my education on hormones began.

Before World War II, about 60 percent of medications in the United States were compounded by pharmacists, until mass production took place in later years, and today compounded drugs are making a comeback with bio identicals in particular. A health-care provider must write a valid prescription and determine that his or her patient needs the drug in a formulation or compound not normally available or approved by the Food and Drug Administration. Compounding has gone on for years with adding a flavor to a cough medicine for a real simple example. Pharmacies that compound are also accredited.

Bioidentical hormones have the same molecular structure as the hormones produced by the body she stated and they can't be patented so this might explain why marketing has not been more aggressive. We see this all the time though with other drugs in other countries too, if there’s not a market, they don’t go there. I asked further about the breast cancer connection and the warnings issued by the FDA years ago, and asked are all hormone replacements pose the same for breast cancer.

She told me the NIH, ACOG, and NAMS recommended doctors take all women off Premarin and other replacement therapies, after the failure of the National Health Initiative, and further stated there are no studies available about bioidentical estrogens of any significance today relative to cancer, even though they have been around since 2002. Where are the studies she asked, and that’ is a very good question indeed. There are many studies from the early 1980s and 1990s and many European studies that prove the safety of bioidenticals, but why have there not been studies conducted with bio identical hormones since the fiasco of WHI (Women’s Health Initiative) in 2002, especially those which are FDA approved and also compare those to the studies conducted with Premarin. I agree with the doctor, we would all like to have some information in that area.

With computer technology data can be collected and tabulated with greater ease and can hopefully start shedding some light. As of today there’s no evidence published that bioidentical estrogens increase the risk of breast cancer or of recurrence. Dr. Schwartz said all we did was end up with lower doses of Premarin on the market instead of teaching women and their doctors of the bioidentical hormones option.

Where are the studies and if they exist, where are they? (Dr. Schwartz quoted from Web MD)

“Erika Schwartz, MD, a New York doctor who prescribes FDA-approved biodentical hormones and compounded bioidentical hormones, says there have been studies that support the safety of bioidentical hormones, compared to other hormone therapy.

Schwartz asks, "If NAMS or ACOG says there are not enough studies, well, why haven't you done the studies if you think you need more? If this had been men's health, would we be having this conversation, or would we have answers?"

Schwartz says she has long wanted to see large, government-sponsored studies compare bioidentical and other hormone therapies head to head.”

We are in the age of personalized medicine and bioidenticals are following this path with personalization without a one size fits all. In medical school, she stated Premarin is still taught as the replacement for hormone therapy.

A short side note of my own here:

(We talk so much about everyone working together and in reference to studies and at least getting some statistics. We have insurance companies that could run some numbers to offer some help along the lines here, as they know what medications patients are taking and which patients have cancer and what kind of cancer. There has been all kinds of talk about working together and supplying the FDA with some of this information in the up and coming Sentinel System that is work in progress; however, do we have to wait until the entire process is ready and available or could one or more of the insurance companies supply some statistics on what they have on file.)

imageWe talked about other drugs that have come to market for hormone treatment. She was very adamant about not using anti depressants for menopause, as many of those drugs have many side effects and are not specifically targeted to treat hot flashes and other menopause symptoms. She stated that either an FDA bio identical hormone or a custom compounded treatment is the better choice, why take an anti depressant if you are not depressed by merely need hormones. Before customizing a solution she stated that she always had a blood test done, so the prescription is precise, and in her practice she preferred this over a swab of saliva, as being more accurate.

A few months ago she was on ExtraTV talking about this exact same subject with reference to Pristiq, which the FDA has given approval to be used for hot flashes, and there are quite a few side effects that come along with that drug such as suicide, as noted on the Wyeth website.

Estrogen metabolism is not simple and has not been well studied. We talked a bit further about new bio identical types of drugs now coming on to the market. Qlaira® being introduced in Europe and Yaz for birth control use approved in the US which contains drospirenone and could increase your potassium. Dr. Schwartz stated that with some of the new drugs and side effects shown, they tend to possibly be “messing with your system” too much with chemically interfering with imageovulation, when all that is necessary is a good hormone treatment plan, exercise, a good diet and some supplements or vitamins to keep you on the right path.

The FDA has warned that "BHRT" (Bio Identical Hormone Treatment) is a marketing term they do not recognize and I asked Dr. Erika about why this is such an issue. She stated that the FDA is set up to only regulate the “one size for all” approach for hormones and all other medications and this may not be the right fit for all women, thus enters the customized approach under the direction of a doctor as you need blood tests to get all the facts before starting a treatment program, and the bio identical hormones are molecularly identical to what we have in our system.

She stated recently when lecturing at Harvard, for example, a much warmer welcome and interest rate has appeared in the last couple years with new interest, those wanting additional knowledge on the subject and how it all comes together. A few years ago it was a different story. Dr. Erika is a conventional doctor with the patients health and interest at heart and offers the solutions needed through BHRT therapy to help both women and men feel better.

Next I inquired about celebrities who have recently spoken out about the use of bio identical hormones, Suzanne Somers and Oprah, as both have somewhat taken their own approaches in discussing how they have been helped. Suzanne Somers has her own marketing approach and a book to sell but she did accomplish bringing the focus to the attention of the public. Dr. Erika commented that Oprah has also been outspoken about how her guided process has been of significant help to her overall well being on television and she would perhaps guess that Oprah has a customized compounded formula created for her. Oprah had quite a bit of publicity, good and bad on the subject and Dr. Erika spoke out commending her on the choices she had made.

I inquired, does everyone need a compounded customized formula? Absolutely not, she said and she prescribes both FDA approved bio identical products as well as a customized formula, it all depends on the patient and their needs, which is her foremost concern, and we don’t have to make an issue complicated if it doesn’t need to be; education and studies are needed and it’s time for women to get the treatments they need for hormone replacement. Once again, she reiterated, we would really like to have some studies to help conventional doctors become helpful for the women who should not be suffering from hormone loss. From my point of view I see this as an extension of “personalized medicine” and once we have studies and perhaps some genomic information in the future to add to it, it will grow from there.

To compliment her entire processes and beliefs, there are many products for sale on the website and you can either purchase products online or read one of her books to find out what you might want to find locally as far as vitamin and other supplements. Just recently (press release below) Dr. Erika was appointed Medical Director of Cinergy Health, an organization that is working to make healthcare affordable with solutions outside the normal realm of health insurance to cover normal and preventive visits, help for those who can’t afford and don’t have customary plans, and hopes soon to bring some additional online consultation sessions to the web.

Along with her website, you can also view many of Dr. Erika’s videos at You Tube, which is a combination of both herself and patients talking about their experiences.

Dr. Erika You Tube Channel

image

The interview was totally enjoyable not to mention educational at the same time, and I thank Dr. Erika for taking time from her busy schedule to talk with me today! The patient is number one in her book, and that’s what we need, doctors who partner with their patients.

Also, we talked about the origins of hormone therapy and I have included a couple links below you might want to explore to see how this all began years ago.

Schering History

The Greatest Experiment Ever Performed on Women

(reminder, double click on any word to get a description or dictionary meaning from any words in the text)

____________________________

Cinergy Health Appoints Dr. Erika Schwartz as Medical Director

Provider of Affordable Health Care Insurance Will Draw on Physicians' Expertise in Preventative Medicine and Patients' Health Advocacy to Enhance Health Plans

AVENTURA, Fla., June 15 /PRNewswire/ -- Cinergy Health, a nationwide provider of affordable health insurance benefit programs for the consumer market, today announced Erika Schwartz MD, as the company's medical director, a new position. As Cinergy Health's medical director, Dr. Schwartz will provide guidance on health care issues, ranging from the efficacy of emerging medical procedures to so-called non-traditional treatment methods, such as the use of nutriceuticals. In addition, she will engage the public in a dialog on ways they can optimize relationships with their own health care professionals.

"We are excited to have Erika join the Cinergy Health team, especially given her broad and deep experience as a patients' health advocate," said Daniel Touizer, CEO of Cinergy Health. "Her work in both hospital-based and private practice gives her a powerful perspective on the entire health care delivery system and what constitutes a proper and effective level of service - all for the benefit of Cinergy Health Plan members."

Over the past 30 years, Dr. Schwartz has personally taken care of more than 100,000 patients, treated more than 15,000 patients with various formulations of bioidentical hormones and has written four best-selling books published by Warner Books, Putnam and HarperCollins. In December 2008, the Medical Clinics of North America published an entire chapter written by Dr. Schwartz on the use of hormones in wellness and disease prevention, a first in the field of conventional medicine. She was invited by the chair of Obstetrics and Gynecology at Harvard to lecture at Massachusetts General Hospital on the topic of bioidentical hormones in February 2009.

"Cinergy Health is an insurance benefits company that actually puts the individual first. Its affordable health insurance coverage is as innovative as any medical breakthrough I've seen," Schwartz said. "Further, Cinergy Health plans are designed to encourage people to seek care, not delay it such that their condition could worsen. As someone who's been involved in patients' rights for years, I am proud to be associated with this company."

Schwartz received her MD from State University of New York Downstate College of Medicine, graduating cum laude, as a member of the prestigious AOA academic honor society. She served as Director of Emergency Medicine at Westchester County Medical Center (University Hospital of New York Medical College) in Valhalla, NY, a world-renowned trauma center. She has been in private practice, in Internal Medicine, for the last 17 years.

As one of the nation's most widely-recognized experts in the field of bioidentical hormones and an outspoken advocate for patients' rights, Dr. Erika Schwartz has testified before Congress, appeared on CBS News, Larry King Live, The View, The Montel Williams Show, CNN, MSNBC, Oprah Satellite Radio with Dr. Oz and many others. Her affiliations include: Board of Managers at SUNY-Downstate College of Medicine, the American Society for Internal Medicine, National Association of Medical Communicators (AMA), International Coenzyme Q10 Society and the Bioidentical Hormone Initiative.

About Cinergy Health

CINERGY HEALTH, Inc., with headquarters in Florida, is a nationwide provider of innovative and affordable health insurance solutions designed to meet the changing needs of American families. Recognizing the financial challenges for people who cannot afford or qualify for costly major medical insurance plans, Cinergy Health designs and delivers lower cost alternative health plans that facilitate access to quality healthcare services and enable people to maintain better health.

Cinergy Health Preferred Insurance Plans are limited medical benefit plans, which provide first dollar coverage for the predictable medical care people need most frequently. These insurance plans provide coverage starting with a member's very first doctor's visit without a deductible so that s/he doesn't put off important medical care. From doctor visits and diagnostics to maternity and surgery, Cinergy provides essential coverage that's easily within most people's budgets. Further, plan member can choose doctors and hospitals of their choice without being confined to a list.

http://sev.prnewswire.com/null/20090615/NY3240215062009-1.html

LUCAS 2 Chest Compression Receives FDA Clearance – Cardiac Arrest

The device is expected to be available for purchase this fall.  It is battery powered and can be life saving.  With the Michael Jackson’s loss of life due to cardiac arrest, no doubt devices as such might be more in the forefront.  The device has been approved in both Europe and Canada as well. 

The device can be used in hospitals and cath labs.  More information with additional images here.  Emergency vehicles such as ambulances of course are right up there on the list.  The device can be more consistent than a human can manually.  BD 

Press release:

FDA Grants LUCAS™ 2 Chest Compression System 510(k) Clearance in the United Statesimage

Next-Generation Product is Electric, Making It the Lightest, Most Compact Device Available for Mechanical Chest Compressions

REDMOND, WASH. / LUND, SWEDEN – June 29, 2009Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today that LUCAS™ 2, the next-generation LUCAS™ Chest Compression System, has been granted 510(k) market clearance by the U.S. Food and Drug Administration (FDA). Developed and manufactured by Jolife AB and distributed exclusively in the United States by Physio-Control, the LUCAS 2 is an automated, battery-powered device that is designed to give consistent, uninterrupted compressions to victims in cardiac arrest.

Since performing manual chest compressions according to the American Heart Association guidelines is both difficult and physically demanding, Jolife created the LUCAS Chest Compression System to assist. LUCAS is designed to deliver uninterrupted compressions at a consistent rate and depth (100 compressions per minute, depth 1.5 to 2 inches) to facilitate the return of spontaneous circulation in cardiac arrest patients. By ensuring consistent blood flow, LUCAS helps emergency medical responders deliver a more viable candidate for recovery to the Emergency Department.  Furthermore, LUCAS can assist in improving the operations of an emergency response system or hospital by helping to reduce the chaos on the scene and free up staff for other emergencies.

LUCAS 2 builds upon the well-proven LUCAS™ 1 technology, but differs from its predecessor in that it is an electric rather than a pneumatic device. LUCAS 2 can be powered either by battery alone or using a wall or car electricity outlet. The battery is the latest in rechargeable, Lithium Ion Polymer technology and operates for up to 45 minutes (typical) on a single battery. LUCAS 2 is equipped with Smart Restart functionality.  When a battery needs to be replaced, LUCAS 2 does not have to be powered down, only put into the pause mode, and when the new battery is inserted, the start position will stay the same within 60 seconds from the pause. Operation can be quickly resumed, saving time for medical personnel.   LUCAS 2 offers other new features such as alerts and pauses to aid ventilation during compressions with an unsecured airway (e.g. bag-valve-mask) and quieter operation. image

“With the LUCAS 2 we now offer a solution to customers that prefer a battery-powered device, and the LUCAS 1 for those who prefer the pneumatic solution,” said Erik von Schenck, CEO of Jolife AB. “The rechargeable battery requires a minimum of maintenance, and makes the device the most compact, lightweight and portable mechanical chest compression device on the market.”

LUCAS 2 weighs only 17.2 lbs (7.8kg) and fits into a compact backpack measuring just 25.6h x 13w x 19.8d inches (65h x 33w x 25d centimeters).

“We are proud that our strong partnership with Jolife has enabled us to bring another high-quality, innovative, life-saving product to the emergency care market,” said Brian Webster, president of Physio-Control. “Customers have been asking us for a battery-powered LUCAS device for a couple of years and with LUCAS 2 we are able to deliver.”

Within the past month, LUCAS 2 has also received a CE (Conformité Européenne) Mark in Europe and marketing approval from Health Canada. Physio-Control plans to begin shipping to the U.S. markets in the fall.

About LUCAS CPR

LUCAS Chest Compression System is an easy-to-use and lightweight device that provides quality chest compressions according to the European Resuscitation Council and American Heart Association Guidelines for CPR (cardiopulmonary resuscitation). It assists rescuers in facilitating the delivery of vital oxygen to the brain and priming the heart for a defibrillation shock in cardiac arrest situations. LUCAS is simple to use, applied within seconds and feasible for use on most cardiac arrest patients. LUCAS is used by firefighters and paramedics on the scene of a cardiac arrest and used by clinical personnel in the emergency departments and cath labs of hospitals. image

About Jolife AB

Jolife AB, founded in 2000, develops and manufactures the LUCAS Chest Compression System. Jolife works closely with leading physicians and paramedics and is committed to research and development in order to continue to offer innovative products. The LUCAS Chest Compression Systems are sold in the major markets in the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic, Inc. – except in Sweden, Norway and Finland, where Jolife sells direct.

About Physio-Control

Physio-Control, a wholly-owned subsidiary of Medtronic, is located in Redmond, Wash. Physio-Control pioneered defibrillation technology more than 54 years ago. With nearly 800,000 LIFEPAK® defibrillators distributed worldwide, the company is the world’s leading provider of external defibrillation and monitoring technology for the treatment of sudden cardiac arrest and other cardio-respiratory emergencies. To find out more about Physio-Control, go to www.physio-control.com or call 1-800-442-1142.   

image

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 24, 2009. Actual results may differ materially from anticipated results.

Have Acne, Accutane Won’t be a Choice for Treatment as Roche has pulled the drug from the US Market

The drug was not withdrawn for not working, more so due to lawsuits and side effects, depression for one.  As noted below, the US is not the first market to have the product withdrawn.  Perhaps Acne will be treated more with medical devices such as this one in the future that was approved by the FDA.image

CLARO Receives FDA-Clearance for Treatment of Acne

Acne problems have also been a bone of contention at times with underwriting insurance in some cases. 

If you Lie – You Die said the Insurance Carrier (You did not report your acne)

Health risks with prescription drugs are important to know about as the complexity of the drugs we take today is increasing.  BD 

June 26 (Bloomberg) -- Roche Holding AG, the world’s biggest maker of cancer drugs, is pulling its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease.

Roche notified the U.S. Food and Drug Administration today that it was withdrawing Accutane after a “reevaluation” of its product lines showed it faced serious challenges from generic competitors, company officials said in a statement. 

“In addition, Roche has been faced with high costs from personal-injury lawsuits that the company continues to defend vigorously,” according to the statement.

Other Countries

The drug also has been pulled off the market in 11 other countries including France, Denmark, Austria, Germany, Portugal, Norway and Spain, Rosenstock said. She couldn’t provide dates for those withdrawals.

Rosenstock said Accutane’s safety wasn’t a factor in the decision to yank it off the U.S. market.

“Roche stands behind the safety of Accutane and the rigorous risk-management program Roche developed over decades of cooperation with the FDA,” she said in the statement.

In November, a state-court jury in New Jersey found company officials didn’t properly warn doctors about Accutane’s health risks and awarded three men a total of $12.9 million in damages.

Roche Pulls Accutane Off Market After Jury Verdicts (Update2) - Bloomberg.com

High Blood Pressure Bluetooth Remote Health Monitor, Glucose Monitor and more – Ideal Life

This company has a few new wireless data reporting medical devices.  The one mentioned in the study was the blood pressure device.  These imagedevices all have Bluetooth too.  There’s also the option of connecting to a phone line to transmit as well. 

The glucose machine is pretty wild, just place your finger on the top and off the information goes.  It will send back a message and motivate or nag you too.  The products on the site look like they are all pretty straight forward.  I do have to say that Blue Tooth devices are certainly changing the way we do and will interact with devices that collect data. 

From the website:

Our scheduled rollout for 2009 includes devices* for managing various cardiac, pulmonary, and weight-related conditions:

  • IDEAL LIFE Sp02-Manager™(pulse oximeter)
  • IDEAL LIFE Breath-Manager™ (peak flow meter)
  • IDEAL LIFE Step-Manager™ (pedometer)
  • IDEAL LIFE Body-Manager Plus™ (chair scale)

It appears the company has more on the line up for this year.  These again all look like new potential HealthVault devices as we are going to need one common place to collect all the data.  The chair scale listed above sounds interesting too as I have never seen one of those.  The study mentions that patients were able to bring their blood pressure back within acceptable ranges with monitoring.  BD

imageimage 

A study reveals that 900 hypertensive patients using Ideal Life remote health management devices to monitor their blood pressure effectively reduced their systolic blood pressure (SYS) by an average of 10 mmHg (millimeters of mercury). For many patients, this decrease brought them below 140 mmHg, the level traditionally defined as the threshold for “high” blood pressure.

Patients Beat High Blood Pressure with Bluetooth Remote Health Monitor |

Inhaled growth hormone safe for children - Study

We are beginning to see more “inhalable” drugs coming on the scene and this is one more that was a small trial, for kids it sure beats having shots and they found that it was well tolerated.  One more potential drug to be delivered through that Bluetooth inhaler, maybe?  BD

More Inhaled Drugs on the Way – Levadex for Migraines Met Trial Goals
The Smart Inhaler with Blue Tooth and Wireless Capabilitiesimage

A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.

Results of the study appear in the June 2009 issue of the Journal of Clinical Endocrinology & Metabolism.

“We need to find less painful ways of administering drugs to children and we were pleased to see that inhaling GH raised the levels of two important indicators in the blood in these children for whom GH was prescribed for growth hormone deficiency or multiple pituitary hormone deficiencies,” said Emily Walvoord, M.D., associate professor of clinical pediatrics at the Indiana University School of Medicine, who is the Riley Hospital physician coordinating investigator of the five-center study of 22 patients.

Inhaled growth hormone safe for children deficient in this key protein | BreakThrough Digest Medical News

Antiperspirants are Considered a Drug by the FDA – Recent Study looks at a connection possible between breast and prostate cancer

The basis of the study is interference of an underarm endocrine organ by antiperspirants, which by the way are considered a “drug” by the FDA, I learn something every day.  This study doesn’t say that we all need to stop using them and start smelling though.  There needs to be additional imageinformation gathered.  The focus is on the hormones as they seem to be the major culprits with both.  By stopping the normal process of perspiration this report is looking at basically whether or not we are disturbing “mother nature’.  Prostate and breast tissues each contain both androgen and estrogen receptors.  By blocking the sweat and not allowing to leave the body, it stays in the skin area and they are potential endocrine disruptors.

Underarm generated hormones and pheromones don’t stink until they mix with bacteria so that means we must all have a bit of that under our arms.  BD

UroToday.com - Prostate and breast cancer appear to be homologous cancer in males and females respectively. Both cancers share hormone etiologies and are treated with hormonal manipulation. The incidence of these two hormone-dependent cancers has steadily risen throughout the twentieth century. Both cancers have race-based links: there is a higher incidence of prostate cancer in African-American men than Caucasian men followed by Asian men and under the age of forty, breast cancer is more lethal in African-American women than Caucasian women and Asian women[1-2] . Beyond genetic and cultural explanations for these differences, an alternative environmental hormone disruptor may be at play as follows.image

Through time the underarms have become more occluded as humankind has progressed from hunting and gathering, to farming, to factory work, to office work, with less physical activity via the automobile, and to the desk at a keyboard. And ironically, thermal sweating from physical activity has been usurped by emotional-stress based sweat, potentially affected by daily interference of an underarm endocrine organ by antiperspirants, furthering underarm occlusion and possibly placing men and women in harm's way.
Thus far, circumstantial historical and multi-discipline observations, although persuasive, are insufficient to conclude an etiological link between antiperspirant and prostate and breast cancer. Further confirmatory investigations are required in an effort to eventually offer prevention and reduced incidence and mortality from the world's two most common hormone-dependent cancers.

Are Antiperspirants Linked To Current Prostate And Breast Cancer Rates?

Survey in the UK shows Most are Worried about cuts at the NHS

Some of those in the survey said raise taxes to protect the NHS and cut back in other areas.  There were mixed reactions too about private insurance and how it comes into play with many disliking the private system option.  I have seen some articles too where writers have created a portrait of imagesome of the private insurers as being less than honest too, such as stealing patient information lists to solicit, etc.  BD

Nine out of 10 people fear that NHS services could be cut and waiting times rise as the government tackles the recession, a survey suggests.

The British Medical Association poll of 1,000 people also found three quarters believed that other public services should take a financial hit instead. 

The union said it showed the depth of feeling about the NHS.

Managers have warned the health service is facing a funding shortfall of up to £10bn for the three years after 2011.

BBC NEWS | Health | Public 'fears NHS spending cuts'

Hand Held Electrocardiogram (ECG) Device – Add 2 Drops to the Device and Send the Information to the Cardiologist or Physician (No paper required)

What won’t we be doing with a portable electronic medical device in the future?  This looks interesting enough and certainly portable.  It is paperlessimage too and results can be uploaded to a PC and it does Bluetooth too.

This looks like one more potential device for the HealthVault to store you ECG.  One the information is sent it goes to the Remote Health Monitoring System for either the physician or designated 3rd party to interpret.  Patients will be able to log on to ensure transmission took place and see their own results.  The control panel can act as an EMR or connect with other EMRs and portals. 

The ICD-9 and CPT Codes for billing information can be read here.  In addition to normal clinical offices, the company lists many other places where the device could be of use, such as on airlines, in labs, at the pharmacy, nursing homes and home care to name a few.  If a patient is on vacation somewhere around the world, the information through the web can still be submitted, so if you are on vacation you can take the device with you.

Again, thinking along here as we are getting more medical data reporting devices out there, I think we are entering the world of “personalized devices” and a PHR will help bring this under one roof, and devices definitely need to be considered when it comes to “meaningful use” by all means.  Must work ok as Dell is certifying and selling the device along with a computer for it to communicate with.  BD 

image

HealthFrontier, together with its technology partner, et medical devices of Italy, has introduced a new innovation in web-enabled electrocardiogram (ECG) technology. The ecg@home, small enough to fit in the palm of a hand, can record a 10-second ECG rhythm strip without electrode cables by just using the thumbs. image

The ecg@home debuted at the Premier healthcare alliance Annual Breakthroughs Conference and Exhibition in Anaheim, CA. It was one of only 26 products selected for showcase at Premier's inaugural Innovation Celebration, an event to celebrate advances in healthcare while highlighting healthcare industry suppliers committed to innovation and improving patient outcomes.

The ecg@home is powered by an IT backbone known as the Remote Health Monitoring System (RHMS). HealthFrontier's RHMS is a web-enabled software application that automatically receives, stores and forwards incoming ECG scans to a patient's Electronic Medical Record, thus eliminating the need for paper printouts. This innovative technology is certified on Dell systems, ensuring easy and seamless connectivity from patient to physician systems. It will be available for purchase both as a stand alone unit and with Dell hardware through the Premier healthcare alliance and through Dell.

image

Also coinciding with the Innovation Celebration is HealthFrontier's announcement of the microtel ecgAnywhere, a compact, hand-held, 12-lead ECG device that is equipped to upload recorded ECG data via Bluetooth, USB or through trans-telephonic transmission

Web Based ECG for Home Use |